Notable Labs Current Ratio 2013-2024 | NTBLQ
Notable Labs current ratio from 2013 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Notable Labs Current Ratio Historical Data |
Date |
Current Assets |
Current Liabilities |
Current Ratio |
2024-06-30 |
$0.01B |
$0.00B |
2.78 |
2024-03-31 |
$0.01B |
$0.00B |
4.66 |
2023-12-31 |
$0.02B |
$0.00B |
5.65 |
2023-09-30 |
$0.02B |
$0.00B |
8.05 |
2023-06-30 |
$0.03B |
$0.01B |
4.63 |
2023-03-31 |
$0.03B |
$0.01B |
3.48 |
2022-12-31 |
$0.00B |
$0.00B |
1.48 |
2022-09-30 |
$0.03B |
$0.01B |
2.82 |
2022-06-30 |
$0.04B |
$0.01B |
4.05 |
2022-03-31 |
$0.05B |
$0.01B |
4.21 |
2021-12-31 |
$0.06B |
$0.01B |
5.53 |
2021-09-30 |
$0.05B |
$0.01B |
6.75 |
2021-06-30 |
$0.06B |
$0.01B |
6.74 |
2021-03-31 |
$0.04B |
$0.01B |
5.55 |
2020-12-31 |
$0.03B |
$0.01B |
4.29 |
2020-09-30 |
$0.04B |
$0.01B |
5.16 |
2020-06-30 |
$0.04B |
$0.01B |
6.41 |
2020-03-31 |
$0.03B |
$0.01B |
4.11 |
2019-12-31 |
$0.04B |
$0.01B |
4.36 |
2019-09-30 |
$0.04B |
$0.01B |
5.49 |
2019-06-30 |
$0.05B |
$0.01B |
6.45 |
2019-03-31 |
$0.05B |
$0.01B |
8.35 |
2018-12-31 |
$0.05B |
$0.01B |
10.83 |
2018-09-30 |
$0.06B |
$0.01B |
11.46 |
2018-06-30 |
$0.06B |
$0.01B |
10.44 |
2018-03-31 |
$0.05B |
$0.01B |
6.59 |
2017-12-31 |
$0.06B |
$0.01B |
7.72 |
2017-09-30 |
$0.03B |
$0.01B |
5.87 |
2017-06-30 |
$0.04B |
$0.01B |
6.48 |
2017-03-31 |
$0.04B |
$0.01B |
9.22 |
2016-12-31 |
$0.05B |
$0.01B |
9.73 |
2016-09-30 |
$0.05B |
$0.00B |
13.12 |
2016-06-30 |
$0.05B |
$0.00B |
12.74 |
2016-03-31 |
$0.03B |
$0.00B |
8.58 |
2015-12-31 |
$0.04B |
$0.00B |
9.28 |
2015-09-30 |
$0.03B |
$0.01B |
5.57 |
2015-06-30 |
$0.03B |
$0.00B |
9.68 |
2015-03-31 |
$0.04B |
$0.00B |
11.96 |
2014-12-31 |
$0.04B |
$0.00B |
12.88 |
2014-09-30 |
$0.01B |
$0.01B |
1.50 |
2014-06-30 |
$0.00B |
|
0.00 |
2014-03-31 |
$0.00B |
|
0.00 |
2013-12-31 |
$0.01B |
$0.00B |
2.68 |
2013-09-30 |
$0.00B |
|
0.00 |
2012-12-31 |
$0.00B |
|
0.00 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-BIOMED/GENE |
$0.000B |
$0.000B |
Notable Labs Ltd. is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Notable Labs Ltd., formerly known as Vascular Biogenics Ltd., is based in FOSTER CITY, Calif.
|